Do you have Hashimoto’s thyroiditis? 
Are you prescribed thyroxine? 
Do you still experience hypothyroid symptoms? 

If you answered yes to the 3 questions above, we invite you to participate in a placebo-controlled study investigating whether low dose naltrexone added to usual thyroxine treatment improves quality of life in people living with hypothyroidism? 

Naltrexone is an approved medication for the treatment of alcohol and opioid dependence. However, naltrexone given in a lower dose may have anti-inflammatory effects that may be beneficial to patients with autoimmune conditions such as Hashimoto’s disease. 

For more information, please contact: 

Dr. Christopher Muir FRACP, PhD

Email: christopher.muir@svha.org.au 

Download Recruitment Flyer

Download Participant Information Sheet

This study has been approved by: St. Vincent’s Hospital Human Research Ethics Committee.